Indonesian Antitrust Regulator Fines Pfizer Units $14M

Law360, New York (September 28, 2010, 2:18 PM EDT) -- Indonesia's antitrust agency KPPU has fined Pfizer Inc. and four subsidiaries a total of about $14 million for violating the country's anti-monopoly statutes by abusing its dominant position in the market for anti-hypertensive drugs to overcharge consumers.

The agency said Tuesday that it had imposed a fine of of 25 billion Indonesian rupiah ($2.8 million) each on Pfizer and subsidiaries PT Pfizer Indonesia, Pfizer Overseas LLC, Pfizer Global Trading and Pfizer Corporation Panama for alleged anti-competitive conduct related to the blood pressure medication amlodipine, which the...
To view the full article, register now.